US Bancorp’s Caribou Biosciences CRBU Stock Holding History

US Bancorp’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.3K	Hold	34,265	–	–	﹤0.01%	2704
2026 Q1	$65.1K	Hold	34,265	–	–	﹤0.01%	2590
2025 Q4	$54.5K	Hold	34,265	–	–	﹤0.01%	2654
2025 Q3	$79.8K	Buy	34,265 +34,082	+18,624%	+$64.3K	﹤0.01%	2451
2025 Q2	$231	Sell	183 -17,335	-99%	-$17K	﹤0.01%	4064
2025 Q1	$16K	Sell	17,518 -9,700	-36%	-$12.6K	﹤0.01%	3272
2024 Q4	$43.3K	Buy	27,218 +26,467	+3,524%	+$53.2K	﹤0.01%	2809
2024 Q3	$1.47K	Sell	751 -696	-48%	-$1.43K	﹤0.01%	3843
2024 Q2	$2.37K	Buy	1,447 +1,206	+500%	+$3.85K	﹤0.01%	3688
2024 Q1	$1.24K	Hold	241	–	–	﹤0.01%	3796
2023 Q4	$1.38K	Hold	241	–	–	﹤0.01%	3761
2023 Q3	$1.15K	Sell	241 -20	-8%	-$124	﹤0.01%	3746
2023 Q2	$1.11K	Sell	261 -503	-66%	-$2.26K	﹤0.01%	3794
2023 Q1	$4.06K	Buy	764 +46	+6%	+$287	﹤0.01%	3589
2022 Q4	$4.51K	Sell	718 -4	-0.6%	-$36	﹤0.01%	3543
2022 Q3	$8K	Sell	722 -501	-41%	-$4.67K	﹤0.01%	3440
2022 Q2	$7K	Buy	+1,223	New	+$9.35K	﹤0.01%	3465

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

US Bancorp's CRBU Position: Q2 2026 in Review

US Bancorp held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 34,265 shares worth $60.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2704.

US Bancorp first reported a position in CRBU in Q2 2022 and has held it in 17 quarters since. The position peaked at $79.8K in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

US Bancorp held 34,265 shares of Caribou Biosciences worth $60.3K as of Q2 2026.
US Bancorp left its Caribou Biosciences share count unchanged in Q2 2026.
Caribou Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2704 holding.
US Bancorp first reported a position in Caribou Biosciences in Q2 2022 and has held it in 17 quarters since.
US Bancorp's Caribou Biosciences position peaked at $79.8K in Q3 2025.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.